http://api.archives-ouvertes.fr/search/INP-NPD?&rows=2000&fq=producedDateY_i:2017&fl=title_s,en_title_s,docid,label_s,en_label_s,authIdHal_s,halId_s,structId_i,uri_s,keyword_s,en_keyword_s,authLastNameFirstName_s,journalTitle_s,abstract_s,en_abstract_s,producedDate_tdate,producedDateY_i,language_s&sort=publicationDate_s+desc
-
Kévin Baranger, Patrizia Giannoni, Stéphane Girard, Sarah Girot, Florence Gaven, et al.. Chronic treatments with a 5-HT4 receptor agonist decrease amyloid pathology in the entorhinal cortex and learning and memory deficits in the 5xFAD mouse model of Alzheimer's disease. Neuropharmacology, 2017, 126, pp.128-141. ⟨10.1016/j.neuropharm.2017.08.031⟩. ⟨hal-01799428⟩
-
Patrizia Giannoni, Bérengère Coupé, Florence Gaven, Caroline Ismeurt, Kévin Baranger, et al.. Microbiote intestinal et maladie d’Alzheimer : une piste stratégique pour des biomarqueurs innovants ?. Biomarker days, Jun 2017, Montpellier, France. ⟨hal-03131344⟩
-
Kévin Baranger, Amandine E Bonnet, Stéphane D Girard, Michel Paumier, Laura García-González, et al.. MT5-MMP Promotes Alzheimer's Pathogenesis in the Frontal Cortex of 5xFAD Mice and APP Trafficking in vitro. Frontiers in Molecular Neuroscience, 2017, 9, pp.163. ⟨10.3389/fnmol.2016.00163⟩. ⟨hal-01479008⟩
-
Manuel Van Gijsel-Bonnello, Kévin Baranger, Philippe Benech, Santiago Rivera, Michel Khrestchatisky, et al.. Metabolic changes and inflammation in cultured astrocytes from the 5xFAD mouse model of Alzheimer's disease: Alleviation by pantethine. PLoS ONE, 2017, 12 (4), pp.e0175369. ⟨10.1371/journal.pone.0175369⟩. ⟨hal-01718180⟩